A very small portion of the U.S. population drives healthcare costs. Costs are so concentrated that just 5% accounts for more than half of health care spending. About 20% of the workforce accounts for 80% of all costs.

A handful of chronic conditions that are amenable to early identification and treatment are the leading cause of death and disability in the United States and account for half of all costs to employers. Modifiable factors are responsible for much of the illness and the subsequent cost of these conditions, but genetics also plays major role. It is now known with good precision what these genetic factors, conditions, and treatments are. Being able to correctly identify the highest risk individuals early-on, before development of chronic conditions and disease, is key to controlling spiraling healthcare costs.

Enter Enscion™

Enscion’s has developed a revolutionary predictive and analytical software system that combines appropriate genetic, clinical, demographic, and lifestyle information to determine an employee’s 2-year, 5-year, 10-year, and lifetime risk of developing certain chronic conditions. These conditions include:

Type 2 Diabetes

Coronary Artery Disease

Colorectal Cancer

Breast Cancer

Prostate Cancer

Lung Cancer

Stroke

Hypertension

Brain Aneurism

Venous Thromboembolism

Atrial Fibrillation

Together, these conditions represent the bulk of the nation’s healthcare and lost productivity costs. Additional pathologies are constantly being added to this list. Enscion’s proprietary software converts the disease risks to the Net Present Value (NPV) of expected future healthcare and lost productivity costs to determine a company’s potential financial exposure. No other similar system exists.

What Enscion’s Software System Does:

Quantifies expected financial exposure of any individual or group

Stratifies any group and identifies the highest potential cost individuals

Determines the most appropriate treatment pathways with the highest ROI

Enscion’s integrated solution provides a detailed and summary medical data analysis that supports better decision making for value-based healthcare and improved patient outcomes. Enscion’s model is forward looking, where the “State-of-the-Art” of predictive modeling is retrospective and typically projects costs only once a person already has a disease. By layering appropriate genetic data on top of traditional analytics, Enscion can discern striking differences in risks and costs between otherwise identical looking individuals.

The Economic Benefits to the Employer

Enscion quantifies the 2, 5, and 10 year risks and expected future healthcare and lost productivity costs, so employers can gain dramatic short-medium term benefits. Enscion’s services can conservatively deliver well over a 100% return on investment just by correctly classifying employees who are at the highest risk of developing expensive chronic diseases -- so they may be put into the most appropriate preventative programs and treatment pathways.

As part of an integrated solution, Enscion provides an interactive iPad/Web application for wellness counselors and physicians, allowing them to show each employee their individual risks of developing these conditions and how they can reduce their risks by changing their most salient lifestyle choices and behaviors. Informing people of their genetic predispositions has been shown to more than double levels of engagement in wellness programs and compliance with medical recommendations.